Cited by 215Inflammatory Bowel DiseaseProbiotics and Fermented FoodsGut microbiota and health

Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double‐blinded, placebo‐controlled multicenter trial

Open access
Tamaki, Hiroyuki, Nakase, Hiroshi, Inoue, Satoko, Kawanami, Chiharu, Itani, Toshinao, Ohana, Masaya, Kusaka, Toshihiro, Uose, Suguru +9 more·2016·Digestive Endoscopy

Abstract

BACKGROUND AND AIM: We conducted a randomized, double-blinded, placebo-controlled trial to investigate the efficacy of Bifidobacterium longum 536 (BB536) supplementation for induction of remission in Japanese patients with active ulcerative colitis (UC). METHODS: Fifty-six patients with mild to moderate UC were enrolled. Three patients had pancolitis, 36 had left-sided colitis, and 17 had proctitis. Patients were randomly treated with 2-3 × 10(11) freeze-dried viable BB536 (28 patients) or placebo (28 patients) for 8 weeks. RESULTS: In total, 63% of patients receiving BB536 showed clinical remission (UC disease activity index [UCDAI] ≤2) at week 8 compared to 52% of those receiving placebo (P = 0.395). We observed a significant decrease of UCDAI scores (3.8 ± 0.4 at baseline to 2.6 ± 0.4 at week 8) in the BB536 group (P < 0.01), whereas there was no significant decrease in the placebo group (P = 0.88). There was also a significant decrease in the Rachmilewitz endoscopic index (EI) and the Mayo subscore at week 8 in the BB536 group, whereas there was no significant decrease in the placebo group. A single patient in the BB536 group complained of a mild side-effect, but no other adverse effects were observed. CONCLUSION: Supplementation with BB536 was well tolerated and reduced UCDAI scores, EI and Mayo subscores after 8 weeks in Japanese patients with mild to moderately active UC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/den.12553

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tamaki, H., Nakase, H., Inoue, S., Kawanami, C., Itani, T., Ohana, M., Kusaka, T., Uose, S., Hisatsune, H., Tojo, M., Noda, T., Arasawa, S., Izuta, M., Kubo, A., Ogawa, C., Matsunaka, T., & Shibatouge, M.
Affiliations
  • Takamatsu Red Cross Hospital (JP)
  • Kyoto University (JP)
  • Kobe Medical Center (JP)
  • Tenri Hospital (JP)
  • Kyoto Katsura Hospital (JP)
  • Kansai Electric Power Hospital (JP)
  • Saiseikai Noe Hospital (JP)
  • Otsu Red Cross Hospital (JP)
  • Department of Gastroenterology Takamatsu Red Cross Hospital Takamatsu Japan
Corresponding author
Tamaki, Hiroyuki
Venue
Digestive Endoscopy
Publisher
Wiley
Published
2015-11-02
Volume
28
Issue
1
Pages
67-74
ISSN
  • 0915-5635 (ISSN-L)
  • 1443-1661
OpenAlex
W1903258410
Cited by
214
References
22
Citations by year
2026: 10 · 2025: 19 · 2024: 34 · 2023: 36 · 2022: 29 · 2021: 21 · 2020: 20 · 2019: 17 · 2018: 15 · 2017: 9 · 2016: 4
FWCI
6.38
Type
journal article
Language
en
Open access
Locations
  • Digestive Endoscopy (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (26893122, 90941, 26460967, 25860532)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, ulcerative colitis, remission induction, Japanese patients, probiotic supplementation
MeSH terms
Administration, Oral, Adult, Bifidobacterium, Colitis, Ulcerative, Colonoscopy, Double-Blind Method, Female, Follow-Up Studies, Humans, Male, Middle Aged, Remission Induction, Retrospective Studies, Time Factors, Treatment Outcome, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review